JP2023533970A5 - - Google Patents
Info
- Publication number
- JP2023533970A5 JP2023533970A5 JP2023501081A JP2023501081A JP2023533970A5 JP 2023533970 A5 JP2023533970 A5 JP 2023533970A5 JP 2023501081 A JP2023501081 A JP 2023501081A JP 2023501081 A JP2023501081 A JP 2023501081A JP 2023533970 A5 JP2023533970 A5 JP 2023533970A5
- Authority
- JP
- Japan
- Prior art keywords
- target
- detection
- item
- biomarker
- lung cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063049538P | 2020-07-08 | 2020-07-08 | |
| US63/049,538 | 2020-07-08 | ||
| PCT/US2021/040971 WO2022011197A1 (en) | 2020-07-08 | 2021-07-08 | Compositions and methods for detection of lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023533970A JP2023533970A (ja) | 2023-08-07 |
| JP2023533970A5 true JP2023533970A5 (enExample) | 2024-07-17 |
Family
ID=79552705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501081A Pending JP2023533970A (ja) | 2020-07-08 | 2021-07-08 | 肺癌を検出するための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240011993A1 (enExample) |
| EP (1) | EP4179106A4 (enExample) |
| JP (1) | JP2023533970A (enExample) |
| KR (1) | KR20230044429A (enExample) |
| CN (1) | CN116113708A (enExample) |
| AU (1) | AU2021305652A1 (enExample) |
| CA (1) | CA3188377A1 (enExample) |
| WO (1) | WO2022011197A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12480940B2 (en) | 2018-05-17 | 2025-11-25 | Meso Scale Technologies, Llc. | Methods for isolating surface marker displaying agents |
| CN114875144B (zh) * | 2022-04-02 | 2026-04-17 | 及智(苏州)医学技术有限公司 | 用于评估肿瘤ibc疗法的疗效的生物标志物、系统、方法及试剂盒 |
| WO2023212315A2 (en) * | 2022-04-29 | 2023-11-02 | Meso Scale Technologies, Llc. | Methods for detecting and isolating extracellular vesicles |
| US20240309453A1 (en) * | 2023-03-13 | 2024-09-19 | Northwestern University | Diagnosis of acute and chronic lung diseases by quantifying spink1 level |
| CN116855605B (zh) * | 2023-06-13 | 2024-06-25 | 中国医学科学院北京协和医院 | Aoc1作为区分卵巢透明细胞癌和高级别浆液性癌的标志物的应用 |
| CN116593693B (zh) * | 2023-07-11 | 2023-09-19 | 四川大学华西医院 | 一种磁性适配体探针、其制备方法和应用及迁移体富集方法 |
| CN117741153A (zh) * | 2023-11-07 | 2024-03-22 | 南京联笃生物科技有限公司 | 一种用于多癌种早期筛查、诊断和/或监测的生物标志物及应用 |
| KR102752505B1 (ko) * | 2024-04-23 | 2025-01-16 | 주식회사 이롬 | 다중오믹스 기반 폐암 진단용 바이오 마커 패널 및 이를 이용한 폐암 진단방법 |
| CN118460477B (zh) * | 2024-07-09 | 2024-11-05 | 苏州唯思尔康科技有限公司 | 一种特别适于内载有效货物的外泌体支架蛋白及其应用 |
| CN119798401B (zh) * | 2024-12-30 | 2025-10-10 | 常州因普迈生物科技有限公司 | 基于pdzk1ip1蛋白的多肽、抗体及其应用 |
| CN120102887B (zh) * | 2025-05-10 | 2025-07-25 | 浙江格物致知生物科技有限公司 | 一种检测肺癌的联检产品及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010056337A2 (en) * | 2008-11-12 | 2010-05-20 | Caris Mpi, Inc. | Methods and systems of using exosomes for determining phenotypes |
| EP2542696B1 (en) * | 2010-03-01 | 2016-09-28 | Caris Life Sciences Switzerland Holdings GmbH | Biomarkers for theranostics |
| EP4170031A1 (en) * | 2012-10-23 | 2023-04-26 | Caris Science, Inc. | Aptamers and uses thereof |
| AU2013361323B2 (en) * | 2012-12-19 | 2018-09-06 | Caris Science, Inc. | Compositions and methods for aptamer screening |
| EP3268476B1 (en) * | 2015-03-09 | 2025-07-16 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| GB201511546D0 (en) * | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| GB201518655D0 (en) * | 2015-10-21 | 2015-12-02 | Olink Ab | Method for generating proximity probes |
| JP7137474B2 (ja) * | 2016-03-15 | 2022-09-14 | メルサナ セラピューティクス，インコーポレイティド | ＮａＰｉ２ｂ標的化抗体－薬物コンジュゲート及びその使用方法 |
| JP2019168223A (ja) * | 2016-08-12 | 2019-10-03 | 公立大学法人和歌山県立医科大学 | エクソソームの膜に存在するタンパク質の検出方法 |
| EP3740567A4 (en) * | 2018-01-18 | 2022-03-09 | Nanosomix Inc. | DETECTION OF EXOSOMES AND EXOSOMAL BIOMARKERS FOR DIAGNOSIS AND PROGNOSIS OF DISEASES AND DISORDERS |
| CN108148912B (zh) * | 2018-03-08 | 2021-10-08 | 四川大学 | 肿瘤的生物标志物、应用和肿瘤检测试剂盒 |
| CN110954703A (zh) * | 2019-12-27 | 2020-04-03 | 杭州迪相实业有限公司 | 一种同时检测外泌体内蛋白和rna、外泌体膜蛋白的方法 |
-
2021
- 2021-07-08 AU AU2021305652A patent/AU2021305652A1/en active Pending
- 2021-07-08 EP EP21836905.6A patent/EP4179106A4/en active Pending
- 2021-07-08 CN CN202180054264.3A patent/CN116113708A/zh active Pending
- 2021-07-08 CA CA3188377A patent/CA3188377A1/en active Pending
- 2021-07-08 JP JP2023501081A patent/JP2023533970A/ja active Pending
- 2021-07-08 US US18/015,051 patent/US20240011993A1/en active Pending
- 2021-07-08 KR KR1020237004288A patent/KR20230044429A/ko active Pending
- 2021-07-08 WO PCT/US2021/040971 patent/WO2022011197A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023533970A5 (enExample) | ||
| JP2022521781A5 (enExample) | ||
| JP7344973B2 (ja) | 標的実体を検出するためのシステム、組成物、及び方法 | |
| Mohan et al. | Profiling of circulating free DNA using targeted and genome-wide sequencing in patients with SCLC | |
| JP2023510911A5 (enExample) | ||
| JP2025504786A5 (enExample) | ||
| JP2023533970A (ja) | 肺癌を検出するための組成物及び方法 | |
| Rimsza et al. | Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues | |
| Lyu et al. | Evaluation of digital PCR assay in detection of M. tuberculosis IS6110 and IS1081 in tuberculosis patients plasma | |
| EP3940086A1 (en) | Kit for early screening of liver cell cancer and preparation method and use thereof | |
| Sypabekova et al. | An aptasensor for the detection of Mycobacterium tuberculosis secreted immunogenic protein MPT64 in clinical samples towards tuberculosis detection | |
| Pu et al. | Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA | |
| Nesvet et al. | Giant magnetoresistive nanosensor analysis of circulating tumor DNA epidermal growth factor receptor mutations for diagnosis and therapy response monitoring | |
| Zhang et al. | Single-cell and spatial transcriptomics reveal SPP1-CD44 signaling drives primary resistance to immune checkpoint inhibitors in RCC | |
| WO2023004083A2 (en) | Compositions and methods for detection of bile duct cancer | |
| WO2023004079A2 (en) | Compositions and methods for detection of liver cancer | |
| WO2023133299A1 (en) | Compositions and methods for detection of lung cancer | |
| JP2024529386A5 (enExample) | ||
| EP3472623A1 (en) | Exosome-guided treatment of cancer | |
| Lee et al. | A high-sensitivity cfDNA capture enables to detect the BRAF V600E mutation in papillary thyroid carcinoma | |
| US20240369560A1 (en) | Compositions and methods for detection of pancreatic cancer | |
| US20240344139A1 (en) | Compositions and methods for detection of colorectal cancer | |
| CN119339805A (zh) | 用于预测对免疫治疗的响应的生物标志物及其应用 | |
| JP2024529918A5 (enExample) | ||
| Lisitsyn et al. | Methods of protein immunoanalysis. |